IPEC Foundation Announces 2014 Award Recipients - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

IPEC Foundation Announces 2014 Award Recipients


The IPEC Foundation recently announced its 2014 Award Recipients, who will be recognized and honored during the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting, Nov. 2 in San Diego.

The winner of the Louis Blecher Outstanding Lifetime Achievement Award is:

Henk de Jong, Scientific Secretary of FIP, the International Pharmaceutical Federation is the winner of the Louis Blecher Outstanding Lifetime Achievement Award. De Jong studied chemistry and physics at Leiden University, the Netherlands, where he obtained an Master’s degree in analytical chemistry. He earned a doctorate on hyphenated chromatographic-spectrometric techniques. He held many positions in academia and industry, was involved in activities at the Dutch, French and European Pharmacopoeias., and is one of the founding fathers of IPEC Europe.

The winner of the Ralph Shangraw Memorial Award is:

Paolo Columbo, PhD, professor of Pharmaceutics, University of Parma was awarded the Ralph Shangraw Memorial Award . Columbo received a doctorate in pharmacy degree; was a professor at the University of Parma, and started a new line of research dedicated to powder for inhalation and pressurized meter dosed inhalers.

The winner of the Industry Research Achievement in Excipient Technology Award:

Ali Rajabi-Siahboomi, PhD, VP and chief scientific officer, Colorcon received the Industry Research Achievement in Excipient Technology Award. He obtained a doctorate in pharmacy from the University of Nottingham (UK). His main research interests are in the area of solid dosage from pharmaceutics and pharmaceutical technology with an emphasis on oral drug delivery systems.

Five Graduate Student Scholarships were awarded to the following individuals:

Zhonggiang (Jacky) Lin, University of Maryland: Quantification of the Extent of Coalescence of Ethylcellulose Films using Permeability and Spectroscopic.

Desai Parind Mahendrakumar, National University of Singapore: Evaluation of functionality of disintegrants and their mixtures by visiometric, calorimetric and quality by design approaches.

Sharad Mangal, Monash University: Engineering of novel core-shell micro-excipient for efficient tablet manufacturing: Employing the concept of interactive mixing.

Pinal Mistry, University of Minnesota: Role of the strength of drug-polymer interactions on the molecular mobility and physical stability of amorphous solid dispersions.

Frederick Osei-Yeboah, University of Minnesota: Effect of moisture on the tableting performance of polymer-based drug delivery systems.

Source: IPEC Foundation

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
8%
All of the above.
46%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing

Click here